Amorena Tompkins, NP
Primary Care · Flint, MINPI 1952861874
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 23 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,045 and has fallen 54.4% since, to $477 in 2025.
Across 23 payments — averaging $94.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$446
- Intra-sana Laboratories$298
- Amgen$125
- Acadia Pharmaceuticals Inc$123
- AstraZeneca$121
- Sage Therapeutics, LLC$120
- plus $942 from 12 others
What the payments were for
- Food & beverage$2,176100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $446 |
| Intra-sana Laboratories | 3 | $298 |
| Amgen | 1 | $125 |
| Acadia Pharmaceuticals Inc | 1 | $123 |
| AstraZeneca | 1 | $121 |
| Sage Therapeutics, LLC | 1 | $120 |
| Madrigal Pharmaceuticals | 1 | $107 |
| Abiomed | 1 | $105 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $104 |
| Gilead | 1 | $100 |
| Sanofi | 1 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Lilly USA, LLC | 1 | $78 |
| Otsuka America Pharmaceutical, Inc. | 1 | $69 |
| Vertex | 1 | $68 |
| Boston Scientific | 1 | $59 |
| Veryan Medical Incorporated | 1 | $49 |
| Cordis US CORP. | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,176 in reported general payments places this provider in the 85th percentile of 292 primary care providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $58,433 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $14,537 |
| MyrbetriqMirabegron | 13 | $8,081 |
| XareltoRivaroxaban | 12 | $7,440 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $3,847 |
| Atorvastatin Calcium | 243 | $2,270 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 78 | $2,270 |
| Levothyroxine Sodium | 178 | $2,256 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $2,143 |
| Duloxetine Hcl | 27 | $1,894 |
| Omeprazole | 131 | $1,846 |
| Divalproex Sodium | 52 | $1,486 |
| Levetiracetam | 54 | $1,347 |
| Famotidine | 46 | $1,234 |
| Lisinopril | 142 | $1,200 |
Paid to pharmacies, not to this prescriber.
Other primary care in Flint
- Jamie BradenFlint$5K
- Donna HamillGrosse Pointe$17K
- Marie Sighe-NzokouLansing$16K
- Alexandria SchwabBay City$10K
- Amy HenryRochester Hills$10K
- Claire GebaraWaterford$9K
- Vanita RobinsonDetroit$9K
- Mary BoudreauMason$9K
- Kimberly FrazierLansing$8K
- Rachel HetznerMadison Heights$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.